Kontrol Technologies Corp (OTCQB:KNRLF, NEO:KNR), a leader in smart buildings and cities through IoT, Cloud, and SaaS technology, announced an updated version of its BioCloud operating software, adding several new features based on customer feedback and demand.
The Toronto-based company said it has also introduced a new health care distribution partner and advanced the BioCloud replacement cartridge longevity.
The BioCloud technology is a real-time analyzer designed to detect airborne viruses and pathogens. It has been designed to operate as a safe space technology by sampling the air quality continuously.
READ: Kontrol Technologies expands use of its BioCLoud technology for HVAC and building systems
“We have advanced the BioCloud technology to approximately double the longevity of the replacement cartridges,” CEO Paul Ghezzi said in a statement.
“We have learned a great deal from our operating units in the field and we continue to develop enhancements which are driven by the needs of our customers. We are also pleased to add a new health care distribution partner as BioCloud continues to attract global interest as a leading ambient air monitoring technology for viruses and pathogens,” he added.
Kontrol said the updated version of the BioCloud software includes important improvements to the overall operation of the technology including advanced optical response data and analytics in real-time.
Additional smart algorithms have been developed to map sensitivity against established baselines with the ability to reset baseline sensitivity in real-time. The software update will be issued as an OTA (over-the-air) update on or around December 13, 2021, it added.
Before the most recent software updates the company said the BioCloud replacement cartridges were able to operate continuously until a singular positive viral or pathogen detection event. With the new version of the software, it said the replacement cartridges can now be deployed for up to two detection events in the majority of cases.
“Our customers had requested that the BioCloud replacement cartridges be designed for potential multiple detection events,” said Gary Saunders, president of Kontrol BioCloud.
“This important enhancement can effectively reduce the long-term operating costs of BioCloud by up to fifty percent. We are continuously working with our customers to deliver advances which are important to them and how they use the BioCloud technology.”
The company said Kontrol BioCloud has added a health organization in the Middle East as a new distribution partner.
Under the terms of the distribution agreement the distribution partner will receive certain regional government exclusivity for any government orders for a period of up to six months.
The new distribution partner operates health clinics in the Middle East with more than 20,000 doctors, healthcare workers and caregivers. Kontrol said the distribution partner’s name would remain confidential for industry competitive purposes.
Kontrol’s customer base includes real estate investment trusts, asset managers and developers with hundreds of millions of square feet under management and in development.
Contact the author at stephen.gunnion@proactiveinvestors.com